David E. Gutstein

6.1k total citations · 2 hit papers
80 papers, 3.3k citations indexed

About

David E. Gutstein is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, David E. Gutstein has authored 80 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Cardiology and Cardiovascular Medicine, 31 papers in Molecular Biology and 15 papers in Surgery. Recurrent topics in David E. Gutstein's work include Cardiac electrophysiology and arrhythmias (22 papers), Connexins and lens biology (19 papers) and Ion channel regulation and function (10 papers). David E. Gutstein is often cited by papers focused on Cardiac electrophysiology and arrhythmias (22 papers), Connexins and lens biology (19 papers) and Ion channel regulation and function (10 papers). David E. Gutstein collaborates with scholars based in United States, Canada and United Kingdom. David E. Gutstein's co-authors include Glenn I. Fishman, Gregory E. Morley, Fangyu Liu, Heidi Stuhlmann, Dhananjay Vaidya, Ju Chen, Houman Tamaddon, Michael Schneider, Kenneth R. Chien and Stephan B. Danik and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

David E. Gutstein

75 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Conduction Slowing and Sudden Arrhythmic Death in Mice With Cardiac-Restricted Inactivation of Connexin43

2001 548 citations David E. Gutstein, Gregory E. Morley et al. profile →
CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy

2024 41 citations David E. Gutstein et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David E. Gutstein United States	32	1.9k	1.5k	403	208	204	80	3.3k
Mitsuo Inada Japan	36	1.9k 1.0×	2.4k 1.6×	474 1.2×	248 1.2×	143 0.7×	211	4.9k
Kazuwa Nakao Japan	37	2.0k 1.1×	833 0.6×	503 1.2×	225 1.1×	192 0.9×	72	4.1k
Lori A. Walker United States	34	1.7k 0.9×	1.1k 0.8×	462 1.1×	195 0.9×	317 1.6×	102	3.7k
Kay‐Dietrich Wagner France	39	2.9k 1.5×	586 0.4×	334 0.8×	196 0.9×	282 1.4×	101	4.2k
Matthew A. Movsesian United States	35	2.7k 1.5×	2.0k 1.3×	463 1.1×	284 1.4×	142 0.7×	72	4.0k
Mutsuo Harada Japan	18	1.2k 0.7×	954 0.7×	405 1.0×	73 0.4×	209 1.0×	34	2.3k
Osamu Nakagawa Japan	29	3.0k 1.6×	1.4k 0.9×	455 1.1×	277 1.3×	250 1.2×	83	5.0k
Jialiang Zhang China	28	2.0k 1.1×	746 0.5×	308 0.8×	58 0.3×	280 1.4×	60	4.3k
Florian Grahammer Germany	35	2.4k 1.3×	515 0.4×	582 1.4×	217 1.0×	259 1.3×	85	4.0k
Abdelkarim Sabri United States	36	1.9k 1.0×	1.4k 1.0×	555 1.4×	157 0.8×	266 1.3×	59	3.5k

Countries citing papers authored by David E. Gutstein

Since Specialization

Citations

This map shows the geographic impact of David E. Gutstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Gutstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Gutstein more than expected).

Fields of papers citing papers by David E. Gutstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Gutstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Gutstein. The network helps show where David E. Gutstein may publish in the future.

Co-authorship network of co-authors of David E. Gutstein

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Gutstein. A scholar is included among the top collaborators of David E. Gutstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Gutstein. David E. Gutstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hermans, Cédric, Carmen Unzu, Mark A. Kay, et al.. (2025). Operationalising a Haemophilia Gene Editing Lexicon for Practical Use. Haemophilia. 31(2). 207–213.

Weitz, Jeffrey I., Aaron Kithcart, Meagan P. O’Brien, et al.. (2025). Efficacy and safety of REGN9933A2 and REGN7508Cat for preventing postoperative venous thromboembolism (ROXI-VTE-I and ROXI-VTE-II): two randomised, open-label, phase 2 trials. The Lancet. 406(10519). 2551–2563.

Schulz, Valerie, Tiffany Woo, C. Assaid, et al.. (2018). Hypersensitivity incidence after sugammadex administration in healthy subjects: a randomised controlled trial. British Journal of Anaesthesia. 121(4). 749–757. 45 indexed citations

Zhou, Xiaoyan, et al.. (2016). A rabbit model of cerebral microembolic signals for translational research: preclinical validation for aspirin and clopidogrel. Journal of Thrombosis and Haemostasis. 14(9). 1855–1866. 8 indexed citations

Barbieri, Christopher M., Xinkang Wang, Weizhen Wu, et al.. (2016). Factor XIIa as a Novel Target for Thrombosis: Target Engagement Requirement and Efficacy in a Rabbit Model of Microembolic Signals. Journal of Pharmacology and Experimental Therapeutics. 360(3). 466–475. 11 indexed citations

Hartmann, Gunther, Sanjeev Kumar, Douglas G. Johns, et al.. (2015). Disposition into Adipose Tissue Determines Accumulation and Elimination Kinetics of the Cholesteryl Ester Transfer Protein Inhibitor Anacetrapib in Mice. Drug Metabolism and Disposition. 44(3). 428–434. 13 indexed citations

Lassman, Michael E., Thomas McAvoy, Anita Y. H. Lee, et al.. (2014). Practical Immunoaffinity-Enrichment LC-MS for Measuring Protein Kinetics of Low-Abundance Proteins. Clinical Chemistry. 60(9). 1217–1224. 29 indexed citations

Anderson, Matt S., Josée Côté, Yang Liu, et al.. (2013). Effects of Rifampin, a Potent Inducer of Drug‐Metabolizing Enzymes and an Inhibitor of OATP1B1/3 Transport, on the Single Dose Pharmacokinetics of Anacetrapib. The Journal of Clinical Pharmacology. 53(7). 746–752. 14 indexed citations

Gutstein, David E., Rajesh Krishna, Douglas G. Johns, et al.. (2011). Anacetrapib, a Novel CETP Inhibitor: Pursuing a New Approach to Cardiovascular Risk Reduction. Clinical Pharmacology & Therapeutics. 91(1). 109–122. 47 indexed citations

10.

Avino, S., Jack A. Barnes, G. Gagliardi, et al.. (2011). Musical instrument pickup based on a laser locked to an optical fiber resonator. Optics Express. 19(25). 25057–25057. 33 indexed citations

11.

Kontogeorgis, Andrianos, Riyaz A. Kaba, Jonathan E. Feig, et al.. (2008). Short-term pacing in the mouse alters cardiac expression of connexin43. BMC Physiology. 8(1). 8–8. 9 indexed citations

12.

Meling, Daryl D., Daniel G. Cyr, David E. Gutstein, et al.. (2007). Proliferation of Adult Sertoli Cells Following Conditional Knockout of the Gap Junctional Protein GJA1 (Connexin 43) in Mice1. Biology of Reproduction. 76(5). 804–812. 184 indexed citations

13.

Gutstein, David E., Gregory E. Morley, & Glenn I. Fishman. (2001). Conditional Gene Targeting of Connexin43: Exploring the Consequences of Gap Junction Remodeling in the Heart. Cell Communication & Adhesion. 8(4-6). 345–348. 31 indexed citations

14.

Rosemblit, Nora, et al.. (1999). Intracellular Calcium Release Channel Expression during Embryogenesis. Developmental Biology. 206(2). 163–177. 89 indexed citations

15.

Fischer, Avi, David E. Gutstein, & Valentı́n Fuster. (1999). THROMBOSIS AND COAGULATION ABNORMALITIES IN THE ACUTE CORONARY SYNDROMES. Cardiology Clinics. 17(2). 283–294. 13 indexed citations

16.

Gutstein, David E. & Valentı́n Fuster. (1998). Pathophysiologic bases for adjunctive therapies in the treatment and secondary prevention of acute myocardial infarction. Clinical Cardiology. 21(3). 161–168. 8 indexed citations

17.

Gutstein, David E. & Valentı́n Fuster. (1998). Revascularization in advanced stable coronary artery disease. Drugs of today. 34(1). 37–37. 11 indexed citations

18.

Gutstein, David E. & Vicente Pascual Fuster. (1997). Management of stable coronary artery disease.. PubMed. 56(1). 99–3. 4 indexed citations

19.

Gutstein, David E. & Andrew R. Marks. (1997). Role of inositol 1,4,5-trisphosphate receptors in regulating apoptotic signaling and heart failure.. PubMed. Suppl 12. 53–7. 23 indexed citations

20.

Kapelko, V. I., et al.. (1996). Abnormal Myocardial Calcium Handling in the Early Stage of Adriamycin Cardiomyopathy. Archives of Physiology and Biochemistry. 104(2). 185–191. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact